Back to search results
NCT07176013

Immersive Virtual Reality Meditation in Voice Therapy

Enrolling by Invitation
NAAges 18+InterventionalTreatment
Icahn School of Medicine at Mount Sinai
~60 participants
Updated 2026-02-04 on ClinicalTrials.gov
What's tested:Voice therapyMeditationVirtual Reality

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Maximum Phonation Time (MPT)
Measured over at each therapy session (approximately 1 week apart over 4 weeks)
+3 more outcomes measured

Conditions

Voice Disorders

Explore related trials

AnxietyOral hypersensitivityVoice Disorder

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Bradley R Hoff, MA, CCC-SLP · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai, Department of Otolaryngology
  • Ümit Daşdöğen, Ph.D., CCC-SLP · STUDY_DIRECTOR · Icahn School of Medicine at Mount Sinai, Department of Otolaryngology

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with voice disorders, difficulties or laryngeal hypersensitivity, and who also have anxiety
Must have availability to participate for entire course of 5 consistent weeks
Presence of any additional medical condition significantly affecting:
Respiratory function (e.g., advanced lung disease)
Laryngeal function (e.g., status-post deep brain stimulation)
Lingual function
Velopharyngeal function (e.g., laryngectomy)

What this trial measures

  • Maximum Phonation Time (MPT)at each therapy session (approximately 1 week apart over 4 weeks)

    MPT will be used to assess participants' maximum phonation time. The speech evaluator instructs the patient to take a comfortable breath and then produce the sound /a/ for as long as possible. The task is performed twice, and the maximum duration of the two measurements is used.

  • Noise-to-Harmonic Ratio (NHR)Pre-intervention (within 1 week before first session) and post-intervention (within 1 week after final session

    NHR is a parameter in MDVP that represents ratio of non-harmonic and harmonic waves in a certain sound wave period. NHR describes the quality of the amount of noise in the sound. Inadequate closure of the vocal cords and periodic vibrations of the vocal cords cause excessive air flow as it passes through the vocal cords, causing turbulence and noise. Normal and periodic sound signals will have a small NHR, while dysphonia sound signals will have a large NHR value.

  • Cepstral Peak Prominence (CPPS)Pre-intervention (within 1 week before first session) and post-intervention (within 1 week after final session

    Cepstral Peak Prominence (CPPS) is an indicator of voice quality. It is measured in decibels. An increase in CPPS value indicates an improvement in voice symptoms.

  • Acoustic Vocal Quality Index (AVQI)Pre-intervention (within 1 week before first session) and post-intervention (within 1 week after final session

    The acoustic voice quality index (AVQI) is a multiparametric score to quantify vocal quality. It is based on a weighted combination of 6 voice parameters: smoothed cepstral peak prominence (CPPS), harmonics-to-noise ratio (HNR), shimmer local (SL), shimmer local dB (SLdB), general slope of the spectrum (slope) and tilt of the regression line through the spectrum (tilt). The formula is constructed as 9.072 - 0.245 × CPPs - 0.161 × HNR - 0.470 × SL + 6.158 × SLdB - 0.071 × Slope - 0.170 × Tilt and ranges from 0 to 10. A lower score correlates with a better vocal quality.